Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics' (DGX) New Buyout Expands Cancer Portfolio
02:06pm, Thursday, 22'nd Jun 2023
Quest Diagnostics (DGX) will use MRD technology to create new blood-based clinical lab services for solid tumour cancers that will be available starting in 2024.
Quest Diagnostics to Release Second Quarter 2023 Financial Results on July 26, 2023
10:00am, Wednesday, 21'st Jun 2023
SECAUCUS, N.J. , June 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter
Quest Diagnostics (DGX) Partners to Offer New Testing Service
12:31pm, Tuesday, 20'th Jun 2023
Quest Diagnostics' (DGX) latest test indicates how different genes and their variants affect how a person reacts to drugs.
Quest Diagnostics' (DGX) Contract Wins Aid Amid Volume Woes
12:29pm, Tuesday, 06'th Jun 2023
Quest Diagnostics (DGX) succeeds on contract wins in its reference and professional lab services offerings.
Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference
11:19am, Friday, 02'nd Jun 2023
SECAUCUS, N.J. , June 2, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at th
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
09:55am, Friday, 02'nd Jun 2023
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and its strategies to accelerate growth.
Zuckerberg unveils Meta's newest VR headset days before Apple reveals its own
10:11am, Thursday, 01'st Jun 2023
The Meta Quest 3 is the successor to the Quest 2 headset that was released in the fall of 2020 at a starting price of $299.
Quest Diagnostics: Healthier Diagnosis
02:09pm, Tuesday, 30'th May 2023
Quest Diagnostics Incorporated has seen modest growth in recent years, although serial buybacks have increased growth on a per-share basis to attractive percentages. The company has been resilient and
Want Growing Passive Income? Consider Buying This Stock
05:48am, Wednesday, 24'th May 2023
Quest Diagnostics' revenue and earnings fell in Q1. The company's low payout ratio should support future dividend growth.
Alzheimer's patients may wait years to get treated with new drugs, putting them at risk of more severe disease
09:00am, Sunday, 30'th Apr 2023
Patients could face wait times ranging from 18 months to four years or more to get diagnosed and then treated for Alzheimer's disease.
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down
12:10pm, Thursday, 27'th Apr 2023
Quest Diagnostics (DGX) base business registers growth in the first quarter of 2023.
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
08:23am, Thursday, 20'th Apr 2023
Quest Diagnostics' (DGX) first-quarter 2023 results are likely to reflect an impressive performance in its non-COVID-19 base business amid inflationary pressure and labor challenges.
Dividend Champion, Contender, And Challenger Highlights: Week Of April 16
04:43am, Sunday, 16'th Apr 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Quest Diagnostics (DGX) Advances Access to Transplant Services
08:23am, Monday, 10'th Apr 2023
Quest Diagnostics' (DGX) upgrade to advanced diagnostics and support services is likely to feature personalized patient access to service centers and mobile phlebotomists.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Thursday, 06'th Apr 2023
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
